Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

17, 2024 – The FDA has approved a new treatment for persistent eczema called Ebglyss that eventually ... swelling and itching of the eye and eyelid, reactions at the injection site, and ...

Adbry ® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in the United States. Adbry is currently indicated in the U.S. for patients 12 years and older with moderate-to-severe atopic ...

The FDA has approved Ebglyss (lebrikizumab-lbkz), a new biologic treatment for moderate-to-severe atopic dermatitis in people ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in ...

Given the dizzying number of anti-ageing skincare ranges out there, it's pretty clear there are a lot of us keen to discover ...

Childhood rashes are common and harmless, and most will disappear without even needing treatment. But if you spot something ... tongue and inside the eyelids for colour changes. Go to A&E or call 999.

Do you often find yourself constantly scratching your skin because it feels dry and uncomfortable? Dry, itchy skin is a ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...

The study, funded by the National Institutes of Health, supports no change to surgical technique for trichiasis management.